A B S T R A C T In vivo and in vitro studies of granulocyte chemotaxis were performed in three patients with the Chediak-Higashi syndrome. Rebuck skin windows showed a decreased accumulation of leukocytes at an inflammatory site. Studies in Boyden chambers documented a cellular defect in granulocyte chemotaxis. The chemotactic response of Chediak-Higashi cells by this technique averaged approximately 40% of normal and was consistently reduced using several different chemotactic stimuli. This deficit was magnified by shortening the chamber incubation time or by decreasing the pore size of the micropore filter and was independent of granulocytopenia. No abnormalities of passive motility, adhesiveness, viability, or pH optimum for migration were found in these cells. Chediak-Higashi serum contained no inhibitors of chemotaxis and was capable of generating normal amounts of chemotactic factors with the exception of one patient with the accelerated phase of the disease. Heterozygotes for the Chediak-Higashi trait had normal chemotactic function. This cellular defect in chemotaxis may contribute to the marked susceptibility to pyogenic infections which is so characteristic of patients with the Chediak-Higashi syndrome.
INTRODUCTION
The Chediak-Higashi syndrome (CHS)1 is a rare disorder, inherited as an autosomal recessive trait, and characterized by recurrent and severe pyogenic infections (1), partial oculocutaneous albinism, and giant cytoplasmic granules found in a number of cell types. Received for publication 12 April 1971 and in revised form 15 June 1971. 1Abbreviations used in this paper: BSA, bovine serum albumin; CHS, Chediak-Higashi syndrome; HPF, highpower field.
The giant granules are most apparent in peripheral blood leukocytes and have many of the characteristics of lysosomes (2) . Animal models of CHS have been described in mink (3, 4) , cattle (4) , and mice (5-7).
Studies of host resistance to infection in this syndrome have centered primarily on leukocyte regulation, and function. Granulocytopenia is a consistent finding in humans with CHS, and studies of granulocyte mobilization have documented decreased marrow granulocyte reserves in spite of adequate numbers of precursors in the marrow (8) . Granulocyte responses to infection are likewise diminished.2 Leukocyte ingestion of bacteria and inert particles is normal in humans (9-13) as well as mink and cattle with CHS (14) . Abnormalities in degranulation, associated in some studies with defective intracellular bactericidal activity have been reported (12) (13) (14) (15) (16) . Abnormal distribution and reduced activity of several lysosomal enzymes have been described (17) . Passive leukocyte motility (10, 18) and migration of granulocytes into the peritoneal cavity of CHS mink and cattle (14) are quantitatively normal.
The study of leukocyte chemotaxis has been greatly facilitated by the Boyden chamber technique (19) , although clinical applications of this method have been limited. Cellular defects in chemotaxis have been described in "toxic" neutrophils from patients with severe acute infections (20) , in two children with recurrent infections and a number of leukocyte abnormalities (21) , as an isolated leukocyte defect in a child with recurrent infections (22) , and by a somewhat different technique.
in patients with diabetes mellitus and rheumatoid arthritis (23, 24) . A few cases have been reported in which there were serum defects in generation of chemotactic factors (25, 26) and, in a single case, a serum inhibitor of chemotaxis (27) . In the present report, a defect in in vitro granulocyte chemotaxis associated with abnor-'Blume, R. S., and S. M. Wolff. Manuscript in preparation.
The Journal of Clinical Investigation Volume 50 1971 mal in vivo leukocyte migration is described in three patients with the Chediak-Higashi syndrome.
METHODS Patients
Since some of the clinical features of the three CHS patients studied have been published elsewhere (28, 29) Chemnotaxis chambers. Chemotaxis chambers consisted of an upper and lower compartment separated by a 5 /A micropore filter (Millipore Corp., Bedford, Mass.). The chemotactic stimulus (2.0 ml) was placed in the lower compartment, and the cell suspension (0.8 ml containing 1.84 X 10°g ranulocytes) was placed in the upper compartment. The chambers were incubated at 370C with 5% carbon dioxide and 100% humidity for exactly 3 hr. In some studies incubation time was varied according to experimental design. The filters were then removed, fixed in methanol, stained with hematoxylin, dried in ethanol, and cleared in xylene.
Stained filters were examined at a magnification of 550 X and the number of cells which had migrated through to the lower surface of the filter was counted in 5-10 random fields. Chemotactic activity was expressed as the average number of cells per high-power field (HPF). The chemotactic response in each individual experiment was taken as the average of four duplicate chamber values. The means of these responses for a number of separate experiments were compared using the standard two sample t test. Standard error is used throughout as an estimate of variance.
RES ULTS
Skin window migration Table I shows the average cellularity score and percentage of granulocytes for each time period in nine skin windows on the three patients with CHS and five in normal subjects. The data were analyzed by calculating a mean score for each individual study over the entire 24 hr time period (normal 3.1 ±0.2, CHS 2.2 +0.3) and by a rank sum test (Friedman test with partitioning of the Chi square [32, 33] ). Both methods showed a significant reduction in the accumulation of cells in the CHS patients (P < 0.05). This deficit was most pronounced for granulocytes, but the later mononuclear phase also appeared to be reduced. The relative numbers of granulocytes and mononuclear cells in the CHS preparations were similar to normal.
Studies of CHS cell chemotaxis
In each experiment, cells from one or more CHS patients were studied concomitantly with cells from one or more normal subjects. The chemotactic stimulus in the lower compartment was generated from both autologous Other chemotactic stimuli (Table III) . An appreciable amount of chemotactic activity is present when fresh human serum is incubated at 370C without endotoxin (35 Kinetics of ceU migration. The results described thus far were all obtained using a 3 hr migration period in the chemotaxis chambers. In additional studies, the time course of granulocyte migration was examined at times varying from 15 min to 7 hr (Fig. 2) . The defect in CHS cell migration was found throughout, but was most pronounced at the earlier time periods (1.0% of normal at 1 hr, 16 .3% at 2 hr, 39.3% at 3 hr, and 55.3% at 4 hr). After 4 hr of incubation, cell counts in both normal and CHS patients diminished considerably probably due to increasing cell death.
Kinetics of granulocyte chemotaxis were studied in three subjects heterozygous for CHS (mother and father of Le. R and La. R. and father of T. H.). At time periods from 1 to 4 hr, the chemotactic responses of cells from heterozygotes were normal. (27) . Apparent inhibition (approximately 80%) was seen with all sera so tested. This is probably explained by the fact that the serum in the upper compartment of the chamber has appreciable intrinsic chemotactic activity and, therefore, reduces the gradient of chemotactic factors across the micropore filter resulting in less migration (19) . In no case was the reduction in cell migration any greater with CHS serum than with normal serum.
Viability and passive motility. Viability was examined by trypan blue exclusion in cells removed from Specificity. The CHS patients studied had a history of frequent infections, and although none was acutely infected when these studies were performed, the diminished chemotaxis observed might have been a nonspecific event accompanying inflammation or repeated infections. Accordingly, studies of chemotaxis were performed on a total of 17 patients with a variety of infectious, inflammatory, or neoplastic diseases (Table  IV) . In none of these subjects was granulocyte chemotaxis significantly reduced from normal controls.
Studies of CHS serum
Serum from each of the three CHS patients was tested for its ability to generate chemotactic activity on incubation with endotoxin (Table V) . While sera from Le. R. and La. R. were both normal, serum from T. H. was consistently deficient when tested with either normal cells (34.3% of normal) or CHS cells (17.0% of normal). Likewise, T. H. serum was also less potent in its intrinsic chemotactic activity present without activation by endotoxin or other agents (mean normal activity 231 ±32 in 10 experiments; mean T. H. activity 111 ±38 in 6 experiments, 48 .1% of normal, P < 0.05). Serum from one CHS heterozygote, the father of T. H., was normal in its ability to generate chemotactic activity.
Since the chemotactic factor produced in both human (10) , but confirms a preliminary study (40) . The results in the present report cannot be attributed to drug therapy since two of the patients (Le. R. and La. R.) were receiving no pharmacologic agents and the patient receiving vincristine (T. H.) was studied 3 wk or more after the last dose. Neutropenia might be an explanation for the failure in the early skin window responses. It has been shown, however, that unless total granulocyte counts are below 1500/mm8, skin window responses are normal (41) . Granulocyte counts in the patients in the present study were generally above this level (mean 1700/mm8). Furthermore, within the group of CHS patients, there was no correlation between individual blood granulocyte counts and mean cellular responses (Spearman rank correlation test [42] ). It seems likely, therefore, that an intrinsic cellular defect rather than neutropenia is responsible for the abnormal responses observed.
The in vitro studies of granulocyte chemotaxis utilizing the Boyden chamber technique clearly demonstrate defective CHS cell migration. The defect was present in all three patients studied, was of similar magnitude for each, persisted over a 4 hr time period, and was present when tested with a number of different chemotactic stimuli. The work of other investigators has demonstrated that the chemotactic factors found in endotoxin-activated serum, nonactivated serum, and bacterial culture filtrates are clearly distinct from one another (31, 35, 38, 39, (43) (44) (45) (46) (47) may be relatively rigid structures and thereby impede the cells' ability to maneuver through the small pores of the chemotaxis chamber filter or to migrate in vivo from the blood to a site of infection. If this is true, the chemotactic defect and the observed failure of granulocyte mobilization (despite adequate numbers of marrow granulocytes and precursors) (8) may have a common basis since studies by Lichtman suggest that leukocyte deformability is important in the egress of cells from the bone marrow (48) .
Very little is known about the mechanism of leukocyte responses to chemotactic factors. The finding of an intrinsic cellular defect in CHS may assume added importance by providing a pathologic model for the study of this process. This point is underscored by recent studies in CHS mink which show a cellular defect in chemotaxis entirely comparable with the current findings in humans (18) .
In another aspect of the present studies sera from two of the CHS patients were normal in their ability to generate chemotactic activity. The defect in generation of chemotactic factors in the serum of the third patient (T. H.) with the accelerated lymphoma-like phase of CHS remains unexplained. The data suggest that hypoglobulinemia, deficient complement levels, or serum inhibitors cannot be implicated.
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Considering the current results in relation to previous studies of CHS, it seems likely that multiple factors including granulocytopenia (8) , poor bone marrow granulocyte mobilization (8) , decreased leukocyte bactericidal capacity (13, 15, 16) , and defective granulocyte chemotaxis are involved in the increased susceptibility to infections characteristic of the Chediak-Higashi syndrome.
